Boston, MA – According to filings with the U.S. Securities and Exchange Commission, Folx Health is raising $25,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, A.G. Breitenstein played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Folx Health

Queer & Trans healthcare delivered on our terms. From HRT, to PrEP, to ED, to STI Care, our Trans and Queer clinicians are here for you. Online access to health care services, diagnostics & prescription drugs through telehealth encounters. Folx offers STD testing, HIV prevention (through Pre Exposure Prophylaxis or PrEP), hormone therapy, fertility testing and general medical information.

To learn more about Folx Health, visit http://www.folxhealth.com/

Contact:
A.G. Breitenstein, Chief Executive Officer
617-792-6855
https://www.linkedin.com/in/a-g-breitenstein-a834715/

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved